Of the one hundred and twenty two patients where the information was available, the hormone receptor negative tumor bearing subjects were characterized by a strikingly lower frequency of TGFB1*CC genotype compared to the hormone receptor positive group (8 of 64 vs 10 of 40; Table S1). This evidence concerns the gene NR4A1 and neoplasm.